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Abstract
Background: The quality of oral and poster conference presentations differ. We hypothesized that the quality of
reporting is better in oral abstracts than in poster abstracts at the American Burn Association (ABA) conference meeting.
Methods: All 511 abstracts (2000: N = 259, 2008: N = 252) from the ABA annual meetings in year 2000 and 2008
were screened. RCT’s and obervational studies were analyzed by two independent examiners regarding study
design and quality of reporting for randomized-controlled trials (RCT) by CONSORT criteria, observational studies by
the STROBE criteria and additionally the Timmer instrument.
Results: Overall, 13 RCT’s in 2000 and 9 in 2008, 77 observational studies in 2000 and 98 in 2008 were identified.
Of the presented abstracts, 5% (oral; 7%(n = 9) vs. poster; 3%(n = 4)) in 2000 and 4% ((oral; 5%(n = 7) vs. poster;
2%(n = 2)) in 2008 were randomized controlled trials. The amount of observational studies as well as experimental
studies accepted for presentation was not significantly different between oral and poster in both years. Reporting
quality of RCT was for oral vs. poster abstracts in 2000 (CONSORT; 7.2 ± 0.8 vs. 7 ± 0, p = 0.615, CI -0.72 to 1.16,
Timmer; 7.8 ± 0.7 vs. 7.5 ± 0.6,) and 2008 (CONSORT; 7.2 ± 1.4 vs. 6.5 ± 1, Timmer; 9.7 ± 1.1 vs. 9.5 ± 0.7). While in
2000, oral and poster abstracts of observational studies were not significantly different for reporting quality
according to STROBE (STROBE; 8.3 ± 1.7 vs. 8.9 ± 1.6, p = 0.977, CI -37.3 to 36.3, Timmer; 8.6 ± 1.5 vs. 8.5 ± 1.4, p =
0.712, CI -0.44 to 0.64), in 2008 oral observational abstracts were significantly better than posters (STROBE score; 9.4
± 1.9 vs. 8.5 ± 2, p = 0.005, CI 0.28 to 1.54, Timmer; 9.4 ± 1.4 vs. 8.6 ± 1.7, p = 0.013, CI 0.32 to 1.28).
Conclusions: Poster abstract reporting quality at the American Burn Association annual meetings in 2000 and 2008
is not necessarily inferior to oral abstracts as far as study design and reporting quality of clinical trials are concerned.
The primary hypothesis has to be rejected. However, endorsement for the comprehensive use of the CONSORT and
STROBE criteria might further increase the quality of reporting ABA conference abstracts in the future.
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Background
Regularly physicians and experts of scientific research
meet in conference to publish their results and to share
information. Mostly, the results are presented in an
abstract form. An abstract should at best provide the
reader with an efficient summary of the study that
facilitates scanning many articles to find those that are
the most pertinent to the reader’s interests and needs [1].
Furthermore, abstracts from expert meetings like annual
meeting of American Burn Association (ABA) are likely
to influence clinical decisions. Therefore, the role and
importance of an abstract is not to be underestimated.
Generally, after an abstract is submitted for a conference
will undergo peer-review. Issues like topic and confer-
ence arrangement are likely to influence the decision
whether a abstract will be presented as poster or oral.
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ken to improve reporting quality of abstracts according to
evidence-based medicine (EBM) criteria. The publication
of the CONSORT Statement in 1996 was an important
step toward improving reporting standards. In 1996, a
group from the Department of Epidemiology and Biosta-
tistics of the Memorial Sloan Kettering Cancer Center in
New York City published their first report entitled:
“Improving the quality of reporting of randomized con-
trolled trials, the CONSORT statement [2]. This was
designed as a guideline to improve quality in reporting
RCTs by using a checklist and a flow diagram [3]. Some of
the items in the checklist include enrollment, intervention
allocation, follow-up, and analysis. Recently the CON-
SORT group has adapted their recommendations to jour-
nal and conference abstracts on RCT’s [4]. The conference
abstracts checklist is strongly recommended by the CON-
SORT group to increase clarification.
Somewhat similar to the aforementioned CONSORT
criteria for randomized-controlled trials, the STROBE
statement has been instituted for observational studies in
order to improve the reporting quality of case-control and
cohort studies. A checklist of 22 items was presented
addressing three main study designs of analytical epide-
miology: cohort, case-control, and cross-sectional studies.
Twenty-three individuals attended a meeting in September
2004, Bristol, UK, including editorial staff from Annals of
Internal Medicine, BMJ, Bulletin of the World Health
Organization, International Journal of Epidemiology,
JAMA, Preventive Medicine, and The Lancet, epidemiolo-
gists, methodologists, statisticians, and practitioners from
Europe and North America. They identified items deemed
to be important to include in checklists for each type of
study and decided on the strategy for finalizing and disse-
minating the STROBE Statement [5].
Timmer et al. noted the lack of an abstract quality eval-
uating instrument and the need to improvement of
abstract quality. In 2003, they developed a reliable and
valid instrument to assess the quality of meeting abstracts
that would be applicable to a wide variety of research
types, including both clinical and basic science [6]. One
of the benefits is Timmer instrument is applicable for all
study designs from metanalyses, RCTs, observational stu-
dies, case studies to experimental studies.
Often times poster abstracts presented at conference
meetings are perceived to be somewhat inferior for yet
unknown reasons. The aim of this study was to deter-
mine the abstract reporting quality in randomized con-
trolled trials and observational studies applying the
CONSORT, STROBE checklist and Timmer instrument.
We hypothesized that poster presented abstracts would




A total number of 511 abstracts presented at the American
Burn Association annual meeting in 2000 (259 abstracts)
and 2008 (252 abstracts) were screened according to the
quality of reporting. According to evidence-based medi-
cine, the study design (randomized controlled trial, obser-
vational study, case series, experimental study) was
determined. Clinical studies with the known study design
according to the level of evidence were discriminated from
experimental studies. In abstracts without mentioned study
design the study design was evaluated based on the method
part, prospective, retrospective, follow-up method, inter-
vention, data gathering method and description of the
results.
A RCT was defined if the abstract described a prospec-
tive study in which individuals are allocated at random to
an intervention or to a controll group. A porspective or
retrospective study that involves identification of two
groups (cohorts) of patients, one which did receive the
exposure of interest, and one which did not, and following
these cohorts forward for the outcome of interest wa s
defined as cohort study. A retrospective study that com-
pared the exposure of individual in two groups, one of
which had the condition under consideration and one
which did not” was definined of a case control study.
Video studies was defined as those which descibed a eva-
luation of a video. Case report was defined as reporting of
an individual or on a series of patients with no control
group, intervention or statistical analysis. Systematical
review was defined as a literature review focused on a sin-
gle question which tries to identify, appraise, select and
synthesis all high quality research evidence relevant to that
question. If the study describes purely about a surgery
technique without control group it was defined as a
describing op technique. If the study was conducted with
any kind of animals, tissue or cells it was defined as an
experimental study. In the study desing was still unlcer or
did not match with the definition above, abstracts were re-
analysed by the researchers (UY and KK) together. The
type and method of intervention was discussed and it was
searched for words like placebo, blinded, random, placebo,
questionare, lab techniques (PCR, western/southern/
northern-blot), odds ratio, relative risk to analyse the
study design.
For each RCT or observational study conference
abstract, the score for CONSORT abstract or STROBE
was calculated by two independent researchers (UY and
KK). The scores of each abstract were compared and the
mean were used when the data varies. Additionally the
timmer instrument was calculated for each abstract and
by inconsistencis again the mean was used. Experimental
studies were not analysed for reporting quality.
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ter, author and institution. The mean score of both inves-
tigators was taken. Interpreter variability was calculated by
t-test (p = 0.873) and Pearson correlation (0.761).
CONSORT criteria for abstract [7] (additional file 1)
were applied for randomised-controlled trial abstracts and
STROBE criteria (additional file 2) for observational stu-
dies. Scores were calculated for 17 CONSORT and 22
STROBE criteria. One point was given if the abstract
meets the items proposed in the criteria and zero points if
not met (CONSORT score range: 0-17, STROBE score
range: 0-22). All individual criteria were weighted equally.
In addition to the CONSORT and STROBE score the
Timmer quality scoring instrument (additional file 3) was
applied for all abstracts. The Timmer instrument consists
of 19 items as a quality index which was developed for the
evaluation of scientific meeting abstracts in a standardized
way. We modified the score calculation to focus on the
reporting quality of the abstracts. Therefore we excluded
the study design in the scoring system and 0-1 points were
given for each item (1 if met, 0 if not met). For the item
which is not applicable, such as controll group (item 5),
randomisation (item 7) or blinding (item 8, 9) of subjects
in observational studies, the points were subtracted from
the score. Therefore for randomized controlled trials the
score range was 0-19 points and for observational studies
0-15 points.
Outcome measures
The study design (randomized controlled trial, non-ran-
domized trial, experimental, prospective, retrospective),
17 CONSORT and 22 STROBE criterias for reporting in
conference abstracts, and the Timmer instrument for
abstract quality were determined.
Statistics
Descriptive statistics consisted of the calculation of fre-
quencies and percentages. T-test was used to calculate and
compare oral vs poster according to CONSORT and
STROBE score in 2000 and 2008 respectively. The Chi-
square tests were applied for assessment of the improve-
ment between each CONSORT and STROBE criteria in
2000 and 2008. Fisher exact tests were used in the analysis
of categorical data where sample sizes were small. Data
were analyzed using the SPSS statistical software package
Version 14.0.
Results
Evidence-based study design of American Burn
Association annual meeting abstracts
Overall, 511 accepted and presented abstracts (2000: N =
259, 2008: N = 252) were screened. 13 RCT’s in 2000 and
9 in 2008, 77 observational studies in 2000 and 98 in 2008
were included for analysis. Of all the presented abstracts
from the annual meeting, 5% (oral; 7%(n = 9) vs. poster;
3%(n = 4)) in 2000 and 4% ((oral; 5%(n = 7) vs. poster; 2%
(n = 2)) in 2008 were randomized controlled trials. There
were no significant differences in the amount of presented
RCTs between oral and poster (2000; p = 0.268 vs. 2008;
p = 0.325). Overall, ABA conference abstracts, 48% were
(oral; 56% (n = 77) vs. poster; 39% (n = 47)) observational
studies in 2000 and 64% (oral; 65% (n = 98) vs. poster;
64% (n = 64)) in 2008. Significantly more observational
studies were presented in 2000 annual meeting (2000; p =
0.006 vs. 2008; p = 0.939). Experimental studies were pre-
sented in 32% (oral; 30% (n = 42) vs. poster; 32% (n = 39),
p = 0.478) and 29% (oral; 29% (n = 244) vs. poster; 30%
(n = 30), p = 0.727) respectively with no statistical differ-
ences (table 1).
CONSORT criteria and Timmer quality instrument for
reporting randomised-controlled trials in annual meeting
abstracts
Reporting quality of RCT was for oral vs. poster abstracts
in 2000 (CONSORT; oral: 7.2 ± 0.8 vs. poster: 7 ± 0) and
2008 (CONSORT; oral: 7.2 ± 1.4 vs. poster: 6.5 ± 1, Tim-
mer; 9.7 ± 1.1 vs. 9.5 ± 0.7) Figure 1). The Timmer instru-
ment for RCTs in ABA 2000 meeting were 7.8 ± 0.7 (oral)
and 7.5 ± 0.6 (poster,), respectively. In 2008 the Timmer
instrument were 9.7 ± 1.1 for oral and 9.5 ± 0.7 for poster
presentations (p = 0.819, CI -1.79 to 2.19, Figure 2). There
were no significant reporting quality differences between
oral and poster presented abstracts. Details of numbers
and percentages for each item are shown on table 2, 3.
STROBE criteria and Timmer quality instrument for
reporting observational studies in annual meeting
abstracts
According to STROBE criteria, the 2000 annual meeting
displayed no significant differences in reporting quality of
observational studies in oral and poster presentations
[oral: 8.3 ± 1.7 (score range: 4-12) vs. poster: 8.9 ± 1.6
(score range: 5-12), p = 0.977, CI -37.3 to 36.3]. Likewise,
the Timmer instrument revealed no significant differences
for oral: [8.6 ± 1.5 (score range: 6-12)] vs. poster abstracts
[8.5 ± 1.4 (score range: 5-12), p = 0.712, CI -0.44 to 0.64].
In 2008, oral presented observational abstracts had a sig-
nificantly better reporting quality than poster presented
abstracts [oral: 9.4 ± 1.9 (score range: 4-13), vs. poster: 8.5
± 2 (score range: 5-14), p = 0.005, CI 0.28 to 1.54, Figure
3]. Also the Timmer instrument was significantly better
for oral vs. poster observational studies in 2008 (oral: 9.4 ±
1.4 (score range: 5-12), vs. poster: 8.6 ± 1.7 (score range:
6-11), p = 0.013, CI 0.32 to 1.28, Figure 4).
The significant differences in 2008 oral and poster
reporting quality in observational studies occured in
the sections objectives (74%(n = 73) vs. 39%(n = 25),
p < 0.001), data sources (32%(n = 31) vs. 17%(n = 11),
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0.004), quantitative variable (12%(n = 12) vs. 2%(n =
1), p = 0.016), and interpretation (87%(n = 85) vs.
100%(n = 64, p = 0.004, table 4, 5)
Discussion
The major findings of this work are: Poster abstract
reporting quality at the American Burn Association
annual meeting of 2000 and 2008 is not necessarily
inferior to oral abstracts as far as study design and
reporting quality of clinical trials is concerned. The pri-
mary hypothesis has to be rejected. However, endorse-
ment for the comprehensive use of the CONSORT and
STROBE criteria might further increase the quality of
reporting ABA conference abstracts in the future.
These observations should be discussed in detail. This is
the first reporting quality evaluation and comparing study
in the field of burn surgery. Evidence-based criteria such
as study design and measure of reporting quality like the
CONSORT and the STROBE score are useful for abstract-
comparison. The increased assessment of study quality has
led to the development of numerous scales and checklists
[8]. In the last years, CONSORT and STROBE checklists
were used more frequently to analyse the reporting quality
in published studies [9,10]. Additionally, calculating a scale
provides readers a quantitative index of trial quality by
assigning a numeric scores to each item present, contri-
buting to an overall total.
In the ABA annual meeting the oral and poster abstract
reporting quality revealed no differences, but the number
of presented RCTs was still very limited with 5% at best.
These results are consistent with other studies especially
in the surgical field [11,12]. A tenyear analysis of publica-
tions in Plastic and Reconstructive Surgery, Annals of
Table 1 Study type of the presented abstract at the BURNS annual meeting 2000 and 2008
2000 2008
oral % poster % p oral % poster % p
RCT 9 7 4 3 0.268 7 5 2 2 0.325
non RCT 87 63 74 61 0.755 101 66 68 68 0.927
Observational 77 56 47 39 0.006* 98 64 64 64 0.939
Other (Video, Case report, Systematical Review, Describing op/new technik) 10 7 27 22 < 0.001* 3 2 4 4 -
Experimental 42 30 39 32 0.478 44 29 30 30 0.727
Drop Out 0 0 4 3 0.046* - - - - -
Total 138 121 152 100
RCT: Randomized-controlled trial, Non-RCT: non-randomized controlled trial
* Statistically significant (p < 0.05)
Drop out: These abstracts were marked in the burns annual meeting abstract-book as “drop out” and were deleted.
Figure 1 Consort-Score in RCT’s. Consort-score in RCT’s- A comarison between oral and poster presentation in 2000 and 2008.
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RCT publication rate of 3.2% [13]. Major reasons for the
lack of RCTs are the complexity of study design asso-
ciated with intensive patient care, expenditure of time
and high costs. And also, ethical considerations in
interventions are a challange in realizing RCTs. However,
a surgical RCT enables optimal properties to minimize
bias in the estimation of the treatment effect which can
otherwise easily be underestimated or exaggerated. RCTs
are widely acknowledged as the gold standard for the
Figure 2 Timmer-Score in RCT’s. Timmer-score in RCT’s-A comarison between oral and poster presentation in 2000 and 2008.
Table 2 Quality of reporting of abstracts at BURNS annual meeting 2000 and 2008 according to the CONSORT criteria
for randomized-control trials
CONSORT 2000 2008
oral poster oral poster
N%N% N %N%
Total 9 100 4 100 7 100 2 100
Title randomized 0 0 1 25 1 14 1 50
Authors 0000 0 000
Trial design 9 100 2 50 6 86 1 50
Participants 8 89 4 100 4 57 0 0
Interventions 9 100 4 100 6 86 2 100
Objective/Hypothesis 9 100 4 100 6 86 2 100
Main Outcome 2 22 0 0 1 14 1 50
Randomization 0000 1 1 4 00
Blinding 22 20 0 4 5 70 0
Number randomized 001 2 5 0 000
Recruitment 0000 0 000
Numbers analyzed 8 89 4 100 3 43 2 100
Outcome 9 100 4 100 7 100 2 100
Harms 0000 1 1 4 00
Conclusion 9 100 4 100 7 100 2 100
Trial registration 0000 0 000
Funding 0000 3 4 3 00
Due to the small sample size p-value was not calculated.
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instrument for randomized-control trials
Timmer instrument for RCTs 2000 2008
oral poster oral Poster
N%n%n%n%
Question/objective sufficiently described? 5 56 4 100 7 100 2 100
Design evident and appropriate to answer study question? 8 89 3 75 6 86 2 100
Subject characteristics sufficiently described? 7 78 0 0 5 71 2 100
Subjects appropriate to the study question? 7 78 3 75 6 86 1 50
Controls used and appropriate? (if no control, check no) 9 100 4 100 7 100 2 100
Method of subject selection described and appropriate? 0 0 0 0 2 29 0 0
If random allocation to treatment groups was possible, is it described? (if not possible, check n/a) 0 0 1 25 1 14 0 0
If blinding of investigators to intervention was possible, is it reported? (If not possible, n/a) 0 0 0 0 1 14 0 0
If blinding of subjects to intervention was possible, is it reported? (If not possible, n/a)
1 22 20034 300
Outcome measure well defined and robust to measurement bias? Means of assessment reported? 7 78 4 100 5 71 2 100
Confounding accounted for? 0 0 0 0 0 0 0 0
Sample size adequate? 00000000
Post hoc power calculations or confidence intervals reported for statistically non significant results? 0 0 0 0 0 0 0 0
Statistical analyses appropriate? 2 22 1 25 3 43 1 50
Statistical tests stated? 0 0 1 25 1 14 1 50
Exact p-values or confidence intervals stated? 7 78 2 50 7 100 2 100
Attrition of subjects and reason for attrition recorded? 0 0 0 0 0 0 0 0
Results reported in sufficient detail? 7 78 3 75 7 100 2 100
Do the results support the conclusions? 9 100 4 100 7 100 2 100
Sum (items 1-19)
Figure 3 Strobe-Score in Observational Studies. Strobe-score in observational studies-A comarison between oral and poster presentation in
2000 and 2008.
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Page 6 of 10Figure 4 Timmer-Score in Observational Studies. Timmer-score in observational studies-A comarison between oral and poster presentation in
2000 and 2008.
Table 4 Quality of reporting of abstracts at BURNS annual meeting 2000 and 2008 according to the STROBE criteria
for observational studies
STROBE 2000 2008
oral poster oral poster
N % n % p-value n % n % p-value
Total 77 100 47 100 98 100 64 100
Title and abstract 0000 - 2212 1
Background/rationale 72 94 46 98 0.407 88 90 64 100 0.012
Objectives 50 65 36 77 0.172 73 74 25 39 < 0.001*
Study design 15 19 12 26 0.428 21 21 16 25 0.621
Setting 27 35 23 49 0.127 46 47 37 58 0.197
Participants 44 57 27 57 0.974 42 43 21 33 0.182
Variables 51 66 29 62 0.609 47 48 37 58 0.245
Data sources/measurement 25 32 18 38 0.508 31 32 11 17 0.037*
Bias 0012 0.379 0000 -
Study size 0000 - 1 2 1 2 00 0.004*
Quantitative variables 9 12 3 6 0.533 12 12 1 2 0.016*
Statistical methods 15 19 7 15 0,512 27 28 10 16 0.072
Participants 30 39 24 51 0.187 56 57 41 64 0.422
Descriptive data 9 12 15 32 0.006* 31 32 23 36 0.601
Outcome data 61 79 43 91 0.083 81 83 58 91 0.198
Main result 66 86 44 94 0.246 81 83 60 94 0.085
Other analysis 0000 - 0000 -
Key result 63 82 43 91 0.19 83 85 61 95 0.066
Limitation 0012 0.379 0000 -
Interpretation 72 94 45 96 0.708 85 87 64 100 0.004*
Generalizability 0000 - 0000 -
Funding 0000 - 2 4 2 4 1 5 2 3 0.85
* Statistically significant (p < 0.05)
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fore the number of RCTs is hopefully to improve in the
future in burn surgery, too [17].
As far as the minimum requirements for future confer-
ence abstracts are concerned, it is rather difficult to pro-
pose detailed suggestions. Following the CONSORT and
STROBE criteria it would be crucial in our view to clearly
note the study design, details on recruitment of partici-
pants, study size randomization, quantitative variables,
main outcome, harms and especially potential funding in
the abstract form to improve reporting quality. These
items would allow the abstract reader to assess the confer-
ence abstract in a more comprehensive way. However,
limited available space has to be considered in this regard.
Depending on conference and journal requirements word
count is usually limited to 250 to 300 words for confer-
ence abstracts. Therefore the abstract format is often
times strictly controlled with background, methods,
results, and conclusions. Thus, investigators are influenced
and guided by these requirements. In addition, the CON-
SORT group has calculated that within 250 to 300 words,
all 17 items of the CONSORT abstract recommendations
are met.
In several studies, it was reported that the information
given for trials in conference proceedings is far from
being optimal [18,19]. Clear, transparent and accurate
reporting or research is important because it enables
readers to understand what was done and to acess the
applicability and relevance of the findings. The extension
of CONSORT aims to improve the reporting in rando-
mized-control trials. However, we believe, beyond the
primary scope of CONSORT for RCT and STROBE for
observational studies, that in general, the abstracts
reporting quality will benefit from the implementation of
standardized criteria to improve the reporting quality,
both in the abstract as well as in a potential subsequent
full manuscript.
Limitations
Several limitations of our study should be noted. First, we
evaluated the quality of reporting, which is not the same
as the methodologic quality of the study. It is possible
that a poorly reported study is well designed and exe-
cuted, and a well-reported one may have several short-
comings. However, empirical evidence exists that
indicates poorly reported studies are associated with lar-
ger estimates of intervention effect, i.e. poor reporting
reflects poor methodology, which in turn is associated
with biased results [20].
Second, given the suggestions of the conference orga-
nizing committee regarding the abstract format and the
restricted word count, it has to take into account that the
implementation of a more comprehensive reporting in
abstracts might be hampered by the abstract require-
ments stated by the conference organizers. Also, submis-
sion and selection process of journals, including author
request of presentation (oral, poster) could influence the
type of presentation. And also it should be acknowledged
Table 5 Quality of reporting of abstracts at BURNS annual meeting 2000 and 2008 according to the STROBE criteria
for observational studies
Timmer instrument for observational studies 2000 2008
oral poster 0ral poster
n%n%n%n%
Question/objective sufficiently described? 50 65 36 77 73 74 25 63
Design evident and appropriate to answer study question? 75 97 46 98 95 97 61 95
Subject characteristics sufficiently described? 45 58 27 57 61 62 36 56
Subjects appropriate to the study question? 68 88 41 87 95 97 54 84
Method of subject selection described and appropriate? 61 79 44 94 81 83 52 81
Outcome measure well defined and robust to measurement bias? Means of assessment reported? 25 32 18 38 73 74 37 58
Confounding accounted for? 0 0 1 2 0 0 0 0
Sample size adequate? 0 0 0 0 12 12 0 0
Post hoc power calculations or confidence intervals reported for statistically non significant results? 0 0 0 0 0 0 0 0
Statistical analyses appropriate? 71 92 35 74 89 91 57 89
Statistical tests stated? 15 19 7 15 27 28 10 16
Exact p-values or confidence intervals stated? 72 92 40 85 90 92 58 88
Attrition of subjects and reason for attrition recorded? 34 44 20 43 54 55 42 66
Results reported in sufficient detail? 74 96 40 85 82 84 61 98
Do the results support the conclusions? 72 94 45 96 89 91 56 88
Sum (items 1-15)
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Therefore request of presentation by author or categori-
sation by journal could be a potential confounder in this
study.
Furthermore, we analysed only studies of evidence level
1++ to 2- according to the Scottish Intercollegiate Guide-
lines Network (SIGN). Because of the low evidence,
experimental studies, new techniques and describing new
concepts were excluded from the analysis. In this context,
laboratory studies and animal studies were classified as
experimental studies. Furthermore, it is possible that the
analysed study designs in abstracts are misinterpertated.
In addition, the CONSORT criteria were suggested pri-
marily for randomized-controlled trials which took only
about 2-7% of study designs in conference abstracts. We
also acknowledge that STROBE is currently limited to
three main observational study designs: cohort, case-con-
trol, and cross-sectional studies. Furthermore the
STROBE criteria were not primary designed for abstracts.
But no other better instrument was available and because
of its specificity for observational studies, we think it was
the best way to evaluate the reporting quality. While no
such statements or checklists for experimental or other
study designs were available, we applied the Timmer
instrument for abstract quality in addition to the afore-
mentioned measures. The Timmer instrument is a valid
quality assessment tool for conference abstracts and
comparing these three instruments for analysing the
abstract quality leads to an increased internal validity and
reliability of the study. In addition, it should be kept in
mind that in this study misclassification in approaching
to CONSORT and STROBE criteria could occur [21]. To
minimize this effect, criteria for reporting in conference
abstracts were analysed by two researchers indepen-
dently. Finally, we compared just two different years,
with two different sets of abstract. This limited amout of
sampling gives some limitation in external validity of
these trials. Therefore further analysis of more data, espe-
cially multiple year comparisons and comparing trends
over time, is needed.
Conclusion
Poster abstracts at the American Burn Association
annual meetings 2000 and 2008 are not necessarily
inferior to oral abstracts as far as study design and
reporting quality of clinical trials are concerned. How-
ever, obligatory use of CONSORT and STROBE criteria
in submitting process of clinical trials, such as the Jour-
nal of Thrombosis and Haemostasisas,a sw e l la st h e
comprehensive use of both criteria by authors indepen-
dently, might further increase the quality of reporting
ABA conference abstracts and help to facilitate peer
review [22] in the future.
Additional material
Additional file 1: CONSORT-Checklist. CONSORT-Checklist for RCT
Additional file 2: STROBE-Checklist. STROBE-Checklist for observational
studies
Additional file 3: Timmer quality scoring instrument for abstract
quality. Timmer quality scoring instrument for abstracts
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